tiprankstipranks
Sangamo Therapeutics (SGMO)
NASDAQ:SGMO
US Market
SGMO
Sangamo Therapeutics
RESEARCH TOOLSreports

Sangamo Therapeutics (SGMO) Balance Sheet

2,627 Followers

Sangamo Therapeutics Balance Sheet

Sangamo Therapeutics's total assets for Q4 2025 were $59.74M, a decrease of -32.60% from the previous quarter. SGMO total liabilities were $74.01M for the fiscal quarter, a -10.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 59.74M$ 101.64M$ 165.32M$ 562.51M$ 721.92M
Total Liabilities
$ 74.01M$ 78.86M$ 82.43M$ 267.55M$ 346.58M
Total Equity Gross Minority
$ -14.27M$ 22.77M$ 82.89M$ 294.96M$ 375.34M
Other Metrics
Currency in USD

Sangamo Therapeutics Debt to Assets